Abstract:BACKGROUNDEsophageal cancer (EC) is the fourth most commonly diagnosed cancer in males and the fifth in females in China. Dysregulation methylation of histone is now considered a biomarker for cancer prognosis.METHODSIn this study, we focused on exploring the expression patterns of two repressor histone methylation marks, H3K9 dimethylation (H3K9me2) and H3K27 trimethylation (H3K27me3), to provide potential biomarkers for diagnosis and therapies in esophageal squamous cell carcinoma (ESCC).RESULTSAfter analyzing the relationship between the expression pattern of H3K27me3 and the clinic-pathological features of ESCC tissues, we found that upregulated H3K27me3 correlated with advanced T stage and N stage. A multivariate Cox regression analysis showed H3K27me3 expression, T stage and N stage were all independent factors for the poor prognosis of ESCC. Therefore, H3K27me3 can be considered an independent factor for predicting the prognosis of ESCC.CONCLUSIONSChromatin remodeling, especially the methylation of H3, plays a vital role in ESCC development and is a potential therapeutic target.

H3K27 Trimethylation and H3K9 Dimethylation As Poor Prognostic Markers for Patients with Esophageal Squamous Cell Carcinoma.